| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | See Remarks
2 companies
Sinha Vikas is a Chief Financial Officer at SRRK, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 41 sales. Those positions are worth an estimated $31.2M at current prices.
Our model assigns Sinha Vikas a strong insider score of 83/100, based on 40 past trades. Over a 12-month horizon, 97.4% of those trades were profitable, with an average 12-month return of +60.5%.
Sinha Vikas's largest disclosed position is in SRRK as Chief Financial Officer, worth about $30.7M. The recent filings there lean toward selling, a net 27,165 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 5,251 | $0.73 | $3,858.43 | -0.5% | +21.3% | -84.8% | |
| Jul 22, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,400 | $0.74 | $2,530.09 | -0.3% | +2.2% | -85.3% | |
| Jul 2, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 939 | $0.72 | $676.08 | - | +10.0% | -84.9% | |
| May 17, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,143 | $0.75 | $2,355.05 | -0.3% | -5.8% | -80.5% | |
| May 3, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 4,957 | $0.80 | $3,945.77 | -0.4% | +0.3% | -68.2% | |
| Apr 22, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,378 | $0.75 | $2,534.41 | -0.3% | -0.6% | -61.5% | |
| Apr 2, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 885 | $0.77 | $683.22 | - | -4.9% | -54.3% | |
| Feb 20, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 2,893 | $0.70 | $2,011.21 | -0.3% | +9.2% | -35.7% | |
| Feb 5, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 18,331 | $0.67 | $12,281.77 | -1.6% | +20.3% | -34.7% | |
| Jan 23, 2024 | KLRS Kalaris Therapeutics, Inc. | See Remarks | Sell | 3,205 | $0.67 | $2,149.91 | -0.3% | +13.9% | -40.3% |